- Waldenström Macroglobulinemia
- Melanoma
- Bladder Cancer
- Brain Cancer
- Breast Cancer
- Childhood Cancers
- Gastric Cancer
- Gynecologic Cancer
- Head & Neck Cancer
- Immunotherapy
- Kidney Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Lymphoma Cancer
- Mesothelioma
- MPN
- MDS
- Myeloma
- Prostate Cancer
- Rare Cancers
- Sarcoma
- Skin Cancer
- Testicular Cancer
- Thyroid Cancer
How a Survivor’s Therapeutic Blogging During Cancer Treatments Turned into Inspiration and Advocacy for Others
In this episode of the “CURE® Talks Cancer” podcast, breast cancer survivor Tomika Bryant discusses her cancer journey, advocacy work and how blogging helped her get through treatment.
Tomika Bryant is a breast cancer survivor, patient advocate and blogger, among other things. She uses her platform and experiences with cancer to support others going through the journey and raise awareness and funding for research.
In this episode of the “CURE® Talks Cancer” podcast, Bryant shares her story, offers advice and discusses her blog, Life in Pumps, as well as her advocacy work.
“Write, journal, because it's therapeutic,” Bryant said. “Don't go to sleep with all that on your mind. It's hard to get rest as is just from dealing with all of the complications and side effects that come from being a cancer patient. But clearing your mind is one of the best ways for when you lay down and go to sleep. So for me, my blog also became that.”
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Fertility Research ‘Long Overdue’ for Patients With Cervical Cancer
November 30th 2023Cervical cancer survivor Kate Weissman talks recent research on follow-up visits for patients after fertility-sparing surgery, and explains why it’s ‘something that the cervical cancer community is owed.’
Listen
Kisqali Plus Endocrine Therapy Improves Survival in HR+/HER2– Breast Cancer
December 6th 2023Patients with HR-positive HER2-negative advanced breast cancer, including elderly patients, derived a progression-free and overall survival benefit with Kisqali plus endocrine therapy compared with placebo plus endocrine therapy.
Read More
